ArticleInternational journal of radiation oncology, biology, physics2017

Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma.

Jennifer Clarke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.